Please assess the completion status of the following clinical trial:

Trial Title: Dexmedetomidine for Immediate Perioperative Analgesia in Pediatric Patients Undergoing Tonsillectomy

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: TRIPLE
- Phase: PHASE4
- Number of Arms: 4.0

Eligibility Criteria:
Inclusion Criteria:~* All of the following criteria must be met for the potential subject to be eligible for participation:~  1. The subject is 2 to 12 years of age~ 2. The subject's American Society of Anesthesiologists physical status is ASA I or II (see appendix 1).~ 3. The subject is scheduled for elective tonsillectomy with or without adenoidectomy surgery (procedures with myringotomy tube placement are allowed).~ 4. The subject will be hospitalized overnight after surgery~ 5. The subject's parent/legally authorized guardian has given written informed consent to participate; and where applicable, the subject has given appropriate assent to participate.~     Exclusion Criteria:~* The potential subject is NOT eligible for participation if any of the following exclusion criteria apply:~  1. The subject has a history or a family (parent or sibling) history of malignant hyperthermia~ 2. The subject has known significant renal or hepatic disorders determined by medical history, physical examination or laboratory tests.~ 3. The subject has a known or suspected allergy to opioid analgesics~ 4. The subject is a pregnant or lactating female (if post-menarcheal, a negative pregnancy test must be confirmed prior to the planned surgery time (in AMSAC) consistent with current standard of care.~ 5. The subject has history of. cardiovascular issues which would preclude the use of dexmedetomidine, (e.g. Down's Syndrome, dysrhthymias, conditions where hypotension is to be avoided).

- Gender: ALL
- Minimum Age: 2 Years
- Maximum Age: 12 Years
- Healthy Volunteers: t

Study Arms:
- Fentanyl 1 (Type: ACTIVE_COMPARATOR): Fentanyl 1 micrograms (mcg)/kilogram (kg)
- Fentanyl 2 (Type: ACTIVE_COMPARATOR): Fentanyl 2 micrograms (mcg)/kilogram (kg)
- Dex 3 (Type: EXPERIMENTAL): Dexmedetomidine 2 micrograms (mcg)/kilogram (kg)
- Dex 4 (Type: EXPERIMENTAL): Dexmedetomidine 4 micrograms (mcg)/kilogram (kg)

Based on this trial design, predict the completion outcome and termination type (if applicable).